QUOTE AND NEWS
Benzinga  Dec 11  Comment 
Analysts at Credit Suisse downgraded United Therapeutics (NASDAQ: UTHR) from Neutral to Underperform. The price target for United Therapeutics has been raised from $100 to $120. United Therapeutics shares have surged 44.98% over the past 52...
Benzinga  Dec 11  Comment 
Market Intelligence Center  Dec 3  Comment 
For a hedged play on United Therapeutics (UTHR), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Feb. '15 $130.00 covered call for a net debit in the $123.53 area. That is also the break-even stock price for the...
Market Intelligence Center  Nov 20  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 5.04% return in just 58 days. Sell one Jan. '15 call at the $125.00 level for each 100...
Market Intelligence Center  Nov 7  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 6.36% return in just 71 days. Sell one Jan. '15 call at the $125.00 level for each 100...
Market Intelligence Center  Oct 23  Comment 
After Wednesday’s trading in United Therapeutics (UTHR) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 9.17% or 27.89% (for comparison purposes only), while providing 11.24%...
Market Intelligence Center  Oct 16  Comment 
United Therapeutics (UTHR) presents a trading opportunity that offers a 9.05% return in just 127 days. A covered call on United Therapeutics at the $120.00 level expiring on Feb. '15 offers an assigned return rate of 9.05% or 26.01% annualized....
Yahoo  Sep 26  Comment 
The CEO of biotech firm United Therapeutics discusses the outlook for biotech and need for public-private partnerships.
Forbes  Sep 25  Comment 
Investors eyeing a purchase of United Therapeutics Corp (NASD: UTHR) shares, but tentative about paying the going market price of $134.28/share, might benefit from considering selling puts among the alternative strategies at their disposal. One...





You may also be interested in articles related to United Therapeutics (UTHR):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki